The finding that most grades II and III gliomas harbor isocitrate dehydrogenase (IDH)
mutations conveying a relatively favorable and fairly similar prognosis in both tumor grades …

Diffuse gliomas are infiltrative primary brain tumors with a poor prognosis despite
multimodal treatment. Maximum safe resection is recommended whenever feasible. The …

The NCCN Guidelines for Central Nervous System (CNS) Cancers focus on management of
adult CNS cancers ranging from noninvasive and surgically curable pilocytic astrocytomas …

Background Emerging evidence suggests survival benefit from resection beyond all MRI
abnormalities present on T1-enhanced and T2‒fluid attenuated inversion recovery (FLAIR) …

Radiologically suspected low-grade gliomas (LGG) represent a special challenge for the
neurosurgeon during surgery due to their histopathological heterogeneity and indefinite …

Safely maximizing extent of resection has become the central goal in glioma surgery.
Especially in eloquent cortex, the goal of maximal resection is balanced with neurological …

OBJECTIVE WHO Grade III gliomas are relatively rare and treated with multiple modalities
such as surgery, chemotherapy, and radiotherapy. The impact of the extent of resection …

Background High-field intraoperative MRI (IoMRI) is part of the neurosurgical
armamentarium to improve the extent of glioma resection (EOR). Objective To report our …

Objective Intraoperative imaging is a chief asset in neurosurgical oncology, it improves the
extent of resection and postoperative outcomes. Imaging devices have evolved …

Gliomas are one of the most common primary central nervous system tumors, and surgical
treatment remains the principal role in the management of any grade of gliomas. In this …